Neurocrine Bets on CRF Biology for Obesity: First-...
Category : Clinical Trial Update 5 May 2026The obesity drug race just got a new contender—and it’s not another GLP-1 copycat. Ne...
Clinical Trial Update
VOXZOGO Strengthens Its Position in Achondroplasia...
Category : Clinical Trial Update 4 May 2026For years, treating Achondroplasia meant managing complications—not changing the disease traje...
Everads Pushes Suprachoroidal Drug Delivery Forwar...
Category : Clinical Trial Update 4 May 2026Retinal drug delivery has a bottleneck: getting enough drug to the back of the eye without invasive...
Spinogenix Targets Blindness at Its Root: Synapse...
Category : Clinical Trial Update 4 May 2026Most eye disease treatments focus on symptoms or slowing damage. Spinogenix Inc. is taking a more ag...
Needle-Free Breakthrough? Vensica’s ViXe Program M...
Category : Clinical Trial Update 1 May 2026There’s a quiet bottleneck in urology. Not innovation. Not demand. Access. And it often comes...
Latest Newsletter Post
-
UCB Drops $2B on Candid Therapeutic..
5 May 2026
-
First New Motion Sickness Drug in 4..
5 May 2026
-
Neurocrine Bets on CRF Biology for..
5 May 2026
-
Spinogenix Targets Blindness at Its..
4 May 2026
-
Everads Pushes Suprachoroidal Drug..
4 May 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com